TABLE 3.
Comparisons among diagnostic groups on demographic and study variables of interest.
| Variable | AD (n = 98) | AUD (n = 46) | AD + AUD (n = 67) | Statistic | P-value |
| Age | M = 51.17 (SD = 15.50)c | M = 54.85 (SD = 15.52)d | M = 42.19 (SD = 9.75)c,d | 13.22a | <000 |
| Gender | |||||
| Male | 65 | 38 | 50 | 4.38b | 0.112 |
| Female | 33 | 8 | 17 | ||
| Race | |||||
| White | 89 | 40 | 61 | 0.63b | 0.730 |
| Non-white | 9 | 6 | 6 | ||
| Highest education level | |||||
| Less than bachelor’s degree | 45 | 22 | 23 | 2.83b | 0.243 |
| Bachelor’s degree or above | 53 | 24 | 44 | ||
| CAGE-AID | M = 2.24e,f (SD = 1.11) | M = 3.02e (SD = 1.04) | M = 3.22f (SD = 0.83) | 20.09a | <000 |
| PMC-5 | M = 2.57 (SD = 0.53) | M = 2.52 (SD = 0.59) | M = 2.71 (SD = 0.64) | 2.43a | 0.174 |
| COVID-19 concern | M = 3.79 (SD = 1.15) | M = 3.72 (SD = 1.20) | M = 4.01 (SD = 1.13) | 0.86a | 0.309 |
aF, bX2. AD, anxiety disorder; AUD, alcohol use disorder; AD + AUD, AD and AUD dual diagnosis; CAGEAID, CAGE adapted to include drugs; PMC-5, pain management collaboratory coronavirus pandemic 5-item measure. Significant differences are denoted by a letter corresponding to the between-group analysis (c–f).